Greetings, I guess you might say I have a "vested interest" in the technology of this company. (more accurately, "like" this company)
I am scheduled for Iodine-125 implants the day after tomorrow by Radiotherapy clinics of Georgia, they have a website at:
cpi-prostate.com:80/
If anyone is interested in learning more about the use of Iodine-125 implants.
I also created a folder in the "coffee shop" area of SI loosely devoted to the discussion of prostate cancer:
Subject 11843
One thing I *CAN* tell you (anyone, not anyone in particular) is that seed implants are the least invasive option for a growing number of PCa patients due to the higher number of patients being diagnosed with "low grade" (I should be so lucky!) tumors. It is also cost effective compared to some other treatment options. (nowhere will you see me use the word "cheap"!)
I would like to know who this company's competitors are? Logically, the more the merrier, ie; competition drives the market, any market.
I do know that Palladium-103 implants are currently "in vogue" and also cost 5X as much as Iodine-125.
If this company is sound, it might be an attractive investment, I am not in the position to say that....the words "prostate cancer" entered in the search box are what brought me here. Anyway, FWIW, seeds are the future IMHO because the PSA blood level test is finding more and more, younger and younger cancer patients....I'm one of them!
To the wise, if you are +/- 40 years old, *especially* if you are of African-American descent, *or* (in my case) have a family history of prostate cancer, you need to know what a PSA blood test is, and probably should consider having one done as a matter or routine during your yearly physical!
Hope this helps,
Hubert
Excerpt from RCOG website
"A blood test called prostate specific antigen (PSA) was developed a few years ago and has revolutionized our ability to evaluate prostate cancer. Thanks to PSA testing, prostate cancer can be detected much earlier than ever before. Hopefully, but this remains uncertain,PSA testing will lead to improved cure rates for prostate cancer.
To date, PSA's only proven role has been in the testing of treatment methods for prostate cancer. When patients are PSA tested after surgery (radical prostatectomy), external irradiation (linear accelerator irradiation) or seed implant only, persistent or regrowing prostate cancer is often discovered (Goluboff, Kuban, Kupelian, Lu-Yao,Schellhammer, Stein, Stock, Wallner). Unfortunately, many physicians and patients have refused to believe medical reports that surgery and external irradiation are not as effective as they were once thought to be. This creates confusion for men with prostate cancer when their treatment options are explained. We think the data presented here give a much needed critical look at the results of therapy both in terms of cure and complications. The purpose of this information, therefore, is to remove as much confusion about prostate cancer as is possible and to help educate men about this disease--how
relatively easy it is to detect and available treatment options. In particular, this material describes a unique treatment approach for prostate cancer--Combined Precision Irradiation (sm), or CPI. Combined Precision Irradiation is the combination of radioactive iodine seed implants in the prostate gland followed by irradiation from a linear accelerator. We believe this simultaneous irradiation method is the most logical treatment in prostate cancer care. " |
